Perinatal Listeria monocytogenes susceptibility despite preconceptual priming and maintenance of pathogen-specific CD8 + T cells during pregnancy

Cellular and Molecular Immunology

Volumn 11, Issue 6, 2014, Pages 595-605

  Clark, Dayna R ^a   Chaturvedi, Vandana ^a   Kinder, Jeremy M ^a   Jiang, Tony T ^a   Xin, Lijun ^a   Ertelt, James M ^a   Way, Sing Sing ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

adaptive immunity; Listeria monocytogenes; perinatal infection; preconceptual vaccination

Indexed keywords

BACTERIAL VACCINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; ALLOANTIGEN; LIVE VACCINE;

ALLOGENEIC PREGNANCY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; DRUG TREATMENT FAILURE; FEMALE; FETUS; FETUS WASTAGE; IMMUNOLOGICAL TOLERANCE; INFECTION SENSITIVITY; INTRAUTERINE INFECTION; LISTERIOSIS; MOUSE; NONHUMAN; PREGNANCY; SECONDARY INFECTION; SYNGENEIC PREGNANCY; VACCINATION; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; COMPLICATION; DISEASE PREDISPOSITION; ETIOLOGY; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; LISTERIA MONOCYTOGENES; MATERNAL CARE; PHYSIOLOGY; PRENATAL EXPOSURE; PREVENTION AND CONTROL;

ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; DISEASE SUSCEPTIBILITY; FEMALE; HISTOCOMPATIBILITY; HUMANS; ISOANTIGENS; LISTERIA MONOCYTOGENES; LISTERIOSIS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; PRECONCEPTION CARE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; VACCINATION; VACCINES, ATTENUATED;

EID: 84908555909     PISSN: 16727681     EISSN: 20420226     Source Type: Journal    
DOI: 10.1038/cmi.2014.84     Document Type: Article

References (76)

1. Centers for Disease Control and Prevention (CDC). Vital signs: Listeria illnesses, deaths, and outbreaks-United States, 2009-2011 MMWR Morb Mortal Wkly Rep 2013; 62: 448-452
2. Gellin BG, Broome CV. Listeriosis. JAMA 1989; 261: 1313-1320
3. Gellin BG, Broome CV, Bibb WF,Weaver RE, Gaventa S, Mascola L. The epidemiology of listeriosis in the United States-1986. Listeriosis Study Group. Am J Epidemiol 1991; 133: 392-401
4. Silver HM. Listeriosis during pregnancy. Obstetr Gynecol Surv 1998; 53: 737-740
5. Southwick FS, Purich DL. Intracellular pathogenesis of listeriosis. N Engl J Med 1996; 334: 770-776
6. Mylonakis E, Paliou M, Hohmann EL, Calderwood SB, Wing EJ. Listeriosis during pregnancy: a case series and review of 222 cases. Medicine 2002; 81(4): 260-269
7. McLauchlin J. Human listeriosis in Britain, 1967-85, a summary of 722 cases 1. Listeriosis during pregnancy and in the newborn. Epidemiol Infect 1990; 104: 181-189
8. Hong MK, Yang CK. Congenital listeriosis: a review of cases in Taiwan since 1990 until 2011. Taiwan J Obstetr Gynecol 2012; 51: 289-291
9. Smith MA, Takeuchi K, Brackett RE, McClure HM, Raybourne RB, Williams KM et al. Nonhuman primate model for Listeria monocytogenes-induced stillbirths. Infect Immun 2003; 71: 1574-1579
10. Gitter M, Richardson C, Boughton E. Experimental infection of pregnant ewes with Listeria monocytogenes. Vet Rec 1986; 118: 575-578
11. Linde K, Fthenakis GC, Lippmann R, Kinne J, Abraham A. The efficacy of a live Listeria monocytogenes combined serotype 1/2a and serotype 4b vaccine. Vaccine 1995; 13: 923-926
12. Bakardjiev AI, Stacy BA, Fisher SJ, Portnoy DA. Listeriosis in the pregnant guinea pig: a model of vertical transmission. Infect Immun 2004; 72: 489-497
13. Guleria I, Pollard JW. The trophoblast is a component of the innate immune system during pregnancy. Nat Med 2000; 6: 589-593
14. Redline RW, Lu CY. Role of local immunosuppression in murine fetoplacental listeriosis. J Clin Invest 1987; 79: 1234-1241
15. WHO. Progress towards eliminating rubella and congenital rubella syndrome in the western hemisphere, 2003-2008 Wkly Epidemiol Rec 2008; 83: 395-400
16. Song N, Gao Z, Wood JG, Hueston L, Gilbert GL, MacIntyre CR et al. Current epidemiology of rubella and congenital rubella syndrome in Australia: progress towards elimination. Vaccine 2012; 30: 4073-4078
17. Black RE, Huber DH, Curlin GT. Reduction of neonatal tetanus by mass immunization of non-pregnant women: duration of protection provided by one or two doses of aluminium-adsorbed tetanus toxoid. Bull World Health Organ 1980; 58: 927-930
18. Newell KW, Duenas Lehmann A, LeBlanc DR, Garces Osorio N. The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial. Bull World Health Organ 1966; 35: 863-871
19. Harrison CJ, Britt WJ, Chapman NM, Mullican J, Tracy S. Reduced congenital cytomegalovirus (CMV) infection after maternal immunization with a guinea pig CMV glycoprotein before gestational primary CMV infection in the guinea pig model. J Infect Dis 1995; 172: 1212-1220
20. Schleiss MR, Lacayo JC, Belkaid Y, McGregor A, Stroup G, Rayner J et al. Preconceptual administration of an alphavirus replicon UL83 (pp65 homolog) vaccine induces humoral and cellular immunity and improves pregnancy outcome in the guinea pig model of congenital cytomegalovirus infection. J Infect Dis 2007; 195: 789-798
21. Roberts CW, Brewer JM, Alexander J. Congenital toxoplasmosis in the Balb/c mouse: prevention of vertical disease transmission and fetal death by vaccination. Vaccine 1994; 12: 1389-1394
22. Haumont M, Delhaye L, Garcia L, Jurado M, Mazzu P, Daminet V et al. Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a guinea pig model. Infect Immun 2000; 68: 4948-4953
23. Negi VD, Nagarajan AG, Chakravortty D. A safe vaccine (DV-STM-07) against Salmonella infection prevents abortion and confers protective immunity to the pregnant and new born mice. PLoS One 2010; 5: e9139.
24. Fowler KB, Stagno S, Pass RF, Britt WJ, Boll TJ, Alford CA. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992; 326: 663-667
25. Beverley JK, Watson WA, Spence JB. The pathology of the foetus in ovine abortion due to toxoplasmosis. Vet Rec 1971; 88: 174-178
26. Roberts CW, Alexander J. Studies on a murine model of congenital toxoplasmosis: vertical disease transmission only occurs in BALB/c mice infected for the first time during pregnancy. Parasitology 1992; 104(Pt 1): 19-23
27. Fensterbank R. Vaccination against Listeria infection in mice with a mutant strain of reduced virulence. Ann Rech Vet 1986; 17: 37-42
28. Edelson BT, Cossart P, Unanue ER. Cutting edge: paradigm revisited: antibody provides resistance to Listeria infection. J Immunol 1999; 163: 4087-4090
29. Lane FC, Unanue ER. Requirement of thymus (T) lymphocytes for resistance to listeriosis. J Exp Med 1972; 135: 1104-1112
30. Mackaness GB. Cellular resistance to infection. J Exp Med 1962; 116: 381-406
31. Miki K, Mackaness GB. The passive transfer of acquired resistance to Listeria monocytogenes. J Exp Med 1964; 120: 93-103
32. Harty JT, Bevan MJ. Responses of CD81 T cells to intracellular bacteria. Curr Opin Immunol 1999; 11: 89-93
33. Pamer EG. Immune responses to Listeria monocytogenes. Nat Rev Immunol 2004; 4: 812-823
34. Hamon M, Bierne H, Cossart P. Listeria monocytogenes: a multifaceted model. Nat Rev Microbiol 2006; 4: 423-434
35. Way SS, Kollmann TR, Hajjar AM, Wilson CB. Cutting edge: protective cell-mediated immunity to Listeria monocytogenes in the absence of myeloid differentiation factor 88. J Immunol 2003; 171: 533-537
36. Rowe JH, Johanns TM, Ertelt JM, Way SS. PDL-1 blockade impedes T cell expansion and protective immunity primed by attenuated Listeria monocytogenes. J Immunol 2008; 180: 7553-7557
37. Ertelt JM, Buyukbasaran EZ, Jiang TT, Rowe JH, Xin L, Way SS. B7-1/ B7-2 blockade overrides the activation of protective CD8 T cells stimulated in the absence of Foxp31 regulatory T cells. J Leuk Biol 2013; 94: 367-376
38. Orgun NN, Way SS. A critical role for phospholipase C in protective immunity conferred by listeriolysin O-deficient Listeria monocytogenes. Microb Pathog 2008; 44: 159-163
39. Hamilton SE, Badovinac VP, Khanolkar A, Harty JT. Listeriolysin Odeficient Listeria monocytogenes as a vaccine delivery vehicle: antigen-specific CD8 T cell priming and protective immunity. J Immunol 2006; 177: 4012-4020
40. Bahjat KS, Liu W, Lemmens EE, Schoenberger SP, Portnoy DA, Dubensky TW Jr et al. Cytosolic entry controls CD81-T-cell potency during bacterial infection. Infect Immun 2006; 74: 6387-6397
41. Brundage RA, Smith GA, Camilli A, Theriot JA, Portnoy DA. Expression and phosphorylation of the Listeria monocytogenes ActA protein in mammalian cells. Proc Natl Acad Sci USA 1993; 90: 11890-11894
42. Foulds KE, Zenewicz LA, Shedlock DJ, Jiang J, Troy AE, Shen H. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J Immunol 2002; 168: 1528-1532
43. Way SS, Havenar-Daughton C, Kolumam GA, Orgun NN, Murali- Krishna K. IL-12 and type-I IFN synergize for IFN-gamma production by CD4 T cells, whereas neither are required for IFNgamma production by CD8 T cells after Listeria monocytogenes infection. J Immunol 2007; 178: 4498-4505
44. Ertelt JM, Johanns TM, Rowe JH, Way SS. Interleukin (IL)-21- independent pathogen-specific CD81 T-cell expansion, and IL-21- dependent suppression of CD41 T-cell IL-17 production. Immunology 2010; 131: 183-191
45. Rowe JH, Ertelt JM, Aguilera MN, Farrar MA, Way SS. Foxp31 regulatory T cell expansion required for sustaining pregnancy compromises host defense against prenatal bacterial pathogens. Cell Host Microbe 2011; 10: 54-64
46. Barber DL, Wherry EJ, Ahmed R. Cutting edge: rapid in vivo killing by memory CD8 T cells. J Immunol 2003; 171: 27-31
47. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76: 17-27
48. Xin L, Ertelt JM, Rowe JH, Jiang TT, Kinder JM, Chaturvedi V et al. Cutting edge: committed Th1 CD41 T cell differentiation blocks pregnancy-induced Foxp3 expression with antigen-specific fetal loss. J Immunol 2014; 192: 2970-2974
49. Tafuri A, Alferink J, Moller P, Hammerling GJ, Arnold B. T cell awareness of paternal alloantigens during pregnancy. Science 1995; 270: 630-633
50. Badovinac VP, Harty JT. Intracellular staining for TNF and IFNgamma detects different frequencies of antigen-specific CD81 T cells. J Immunol Methods 2000; 238: 107-117
51. Barber EM, Fazzari M, Pollard JW. Th1 cytokines are essential for placental immunity to Listeria monocytogenes. Infect Immun 2005; 73: 6322-6331
52. Mor G, Cardenas I. The immune system in pregnancy: a unique complexity. Am J Reprod Immunol 2010; 63: 425-433
53. Rowe JH, Ertelt JM, Xin L, Way SS. Regulatory T cells and the immune pathogenesis of prenatal infection. Reproduction 2013; 146: R191-203
54. Kagi D, Ledermann B, Burki K, Hengartner H, Zinkernagel RM. CD81 T cell-mediated protection against an intracellular bacterium by perforindependent cytotoxicity. Eur J Immunol 1994; 24: 3068-3072
55. San Mateo LR, Chua MM, Weiss SR, Shen H. Perforin-mediated CTL cytolysis counteracts direct cell-cell spread of Listeriamonocytogenes J Immunol 2002; 169: 5202-5208
56. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281: 1191-1193
57. Riella LV, Dada S, Chabtini L, Smith B, Huang L, Dakle P et al. B7h (ICOS-L) maintains tolerance at the fetomaternal interface. Am J Pathol 2013; 182: 2204-2213
58. Guleria I, Khosroshahi A, Ansari MJ, Habicht A, Azuma M, Yagita H et al. A critical role for the programmed death ligand 1 in fetomaternal tolerance. J Exp Med 2005; 202: 231-237
59. Blois SM, Ilarregui JM, Tometten M, Garcia M, Orsal AS, Cordo-Russo Ret al. A pivotal role for galectin-1 in fetomaternal tolerance. Nat Med 2007; 13: 1450-1457
60. Rowe JH, Ertelt JM, Xin L, Way SS. Pregnancy imprints regulatory memory that sustains anergy to fetal antigen. Nature 2012; 490: 102-106
61. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat Immunol 2004; 5: 266-271
62. Steinhoff MC. Assessments of vaccines for prenatal immunization. Vaccine 2013; 31(Suppl 4): D27-D30
63. Steinhoff MC, Omer SB, Roy E, Arifeen SE, Raqib R, Altaye M et al. Influenza immunization in pregnancy-antibody responses in mothers and infants. N Engl J Med 2010; 362: 1644-1646
64. Krishnan L, Pejcic-Karapetrovic B, Gurnani K, Zafer A, Sad S. Pregnancy does not deter the development of a potent maternal protective CD81 T-cell acquired immune response against Listeria monocytogenes despite preferential placental colonization. Am J Reprod Immunol 2010; 63: 54-65
65. Harty JT, Bevan MJ. Specific immunity to Listeria monocytogenes in the absence of IFN gamma. Immunity 1995; 3: 109-117
66. White DW, Badovinac VP, Fan X, Harty JT. Adaptive immunity against Listeria monocytogenes in the absence of type I tumor necrosis factor receptor p55. Infect Immun 2000; 68: 4470-4476
67. White DW, Badovinac VP, Kollias G, Harty JT. Cutting edge: antilisterial activity of CD81 T cells derived from TNF-deficient and TNF/perforin double-deficient mice. J Immunol 2000; 165: 5-9
68. Le Monnier A, Autret N, Join-Lambert OF, Jaubert F, Charbit A, Berche P et al. ActA is required for crossing of the fetoplacental barrier by Listeria monocytogenes. Infect Immun 2007; 75: 950-957
69. Bakardjiev AI, Stacy BA, Portnoy DA. Growth of Listeria monocytogenes in the guinea pig placenta and role of cell-to-cell spread in fetal infection. J Infect Dis 2005; 191: 1889-1897
70. Le Monnier A, Join-Lambert OF, Jaubert F, Berche P, Kayal S. Invasion of the placenta during murine listeriosis. Infect Immun 2006; 74: 663-672
71. Nancy P, Tagliani E, Tay CS, Asp P, Levy DE, Erlebacher A. Chemokine gene silencing in decidual stromal cells limits T cell access to the maternal-fetal interface Science 2012; 336: 1317-1321
72. Bakardjiev AI, Theriot JA, Portnoy DA. Listeria monocytogenes traffics from maternal organs to the placenta and back. PLoS Pathog 2006; 2: e66.
73. Brincks EL, Roberts AD, Cookenham T, Sell S, Kohlmeier JE, Blackman MA et al. Antigen-specific memory regulatory CD41Foxp31 T cells control memory responses to influenza virus infection. J Immunol 2013; 190: 3438-3446
74. Chen ML, Pittet MJ, Gorelik L, Flavell RA, Weissleder R, von Boehmer H et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci USA 2005; 102: 419-424
75. Dai Z, Li Q, Wang Y, Gao G, Diggs LS, Tellides G et al. CD41CD251 regulatory T cells suppress allograft rejection mediated by memory CD81 T cells via a CD30-dependent mechanism. J Clin Invest 2004; 113: 310-317
76. Elahi S, Ertelt JM, Kinder JM, Jiang TT, Zhang X, Xin L et al. Immunosuppressive CD711 erythroid cells compromise neonatal host defence against infection. Nature 2013; 504: 158-162.